A comparison of the effects of the 5HT1A antagonists MM-77 and WAY-100635 on the mouse isolated vasa deferentia

Autonomic and Autacoid Pharmacology

Volumn 25, Issue 3, 2005, Pages 121-128

  Arkle, M J ^a   Arkle, S ^a   Ebenezer, I S ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

adrenoceptor; 5 HT1A receptors; Adrenergic; MM 77; Phenylephrine; Vas deferens mouse; Vasa deferentia; WAY 100635

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 SUCCINIMIDOBUTYL)PIPERAZINE; ALPHA 1 ADRENERGIC RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PHENYLEPHRINE; PIPERAZINE DERIVATIVE; RECEPTOR SUBTYPE; SEROTONIN 1 ANTAGONIST; SEROTONIN 1A ANTAGONIST; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG; PYRIDINE DERIVATIVE; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST; VASOCONSTRICTOR AGENT;

ADRENERGIC ACTIVITY; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROSTIMULATION; IC 50; MALE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; VAS DEFERENS; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; PHYSIOLOGY; SMOOTH MUSCLE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; MALE; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHENYLEPHRINE; PIPERAZINES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS; SUCCINIMIDES; VAS DEFERENS; VASOCONSTRICTOR AGENTS;

EID: 21244441551     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2005.00341.x     Document Type: Article

References (35)

1. 1-adrenoceptor blockade. Gen. Pharmacol., 34, 357-362.
2. 1A receptors. Eur. J. Pharmacol., 408, 273-276.
3. 1A agonist MM-77 on feeding in rats. Proc. Br. Pharmacol. Soc. Available at: http:// www.pa2online.org/Vol2Issuelabst017P.
4. 1A antagonist MM-77 with WAY-100635 on the mouse isolated vasa deferentia. Proc. Br. Pharmacol. Soc. Available at: http://www.pa2online.org/Vol2Issue2abst056P.
5. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 48-58.
6. 2- adrenoceptors. J. Auton. Pharmacol., 11, 247-253.
7. 1- adrenoceptors on rabbit aorta. Eur. J. Pharmacol., 14, 141-148.
8. COHN, J.B. & WILCOX, C.S. (1987). Buspirone effectiveness, safety and mechanisms of action. Intern. Med. Spec., 8, 216-224.
9. COOPER, J.R., BLOOM, F.E. & ROTH, R.H. (1991). The Biochemical Basis of Neuropharmacology. Oxford University Press, New York.
10. DOURISH, C.T., HUTSON, H. & CURSON, G. (1985). Characteristics of feeding induced by the serotonin agonist 2-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Brain Res. Bull., 15, 377-384.
11. 1A agonist, 8-OH-DPAT, on operant food intake in non-deprived rats. NeuroReport, 3, 62-64.
12. 1A agonist, 8-OH-DPAT, on operant food intake in deprived rats. NeuroReport, 3, 1019-1022.
13. 1A receptor agonists 8-OH-DPAT on operant food intake in food-deprived pigs. Physiol. Behav., 67, 213-217.
14. 1A receptors. Physiol. Behav., 73, 223-227.
15. 1A-adrenoceptors. Eur. J. Pharmacol., 4, 33-44.
16. 1A receptor antagonist. Br. J. Pharmacol., 112, 91P.
17. 1A receptor antagonist. Behav. Brain Res., 73, 337-353.
18. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol., 281, 81-88.
19. FURCHGOTT, R.F. (1972). The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Catecholamines, Handbook of Experimental Pharmacology, Vol. 33 (Eds H. BLASCHKO & E. MUSCHOLL), pp. 283-335. Springer, Berlin.
20. 2- adrenoceptor antagonist activity may account for the effects of buspirone in an anticonflict test in the rat. Eur. J. Pharmacol., 155, 129-137.
21. 1- adrenoceptor binding sites. Naunyn Schmiedebergs Arch. Pharmacol., 336, 597-607.
22. HENDRY, I.A. (1975). The response of adrenergic neurones to axotomy and nerve growth factor. Brain Res., 94, 87-97.
23. 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rats brain in vivo. Naunyn Schmiedebergs Arch. Pharmacol., 338, 463-471.
24. KENAKIN, T.P. (1984). The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev., 36, 165-222.
25. KITCHEN, I. (1984). Textbook of In Vitro Practical Pharmacology. Blackwell Scientific Publications, Oxford. ISBN 0 632 01216 1.
26. 1A receptor antagonist and its analogs. J. Med. Chem., 37, 2754-2760.
27. 1A receptor ligand with the same activity profile as buspirone. J. Med. Chem., 39, 1125-1129.
28. 1A receptor ligand. Bio. Med. Chem., 7, 287-295.
29. 11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET. Nuclear Med. Biol., 23, 627-634.
30. 1A-adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivity. Bioorg. Med. Chem., 8, 2495-2500.
31. SMITH, C.F. & CUTTS, S. (1990). Dopamine agonist activity of 8-OH-DPAT. Arch. Int. Pharmacodyn. Ther., 306, 106-113.
32. 1B agonists. Synapse, 1, 3-9.
33. 1A receptors. J. Auton. Pharmacol., 11, 237-245.
34. TRUMPP-KALLMAYET, S., HOFLACK, J., BRUINVELS, A. & HIBERT, M. (1992). Modeling of G-protein coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine and mammalian opsin receptors. J. Med. Chem., 35, 3448-3462.
35. 1-adrenoceptor blockade in the adult rat. Auton. Autacoid Pharmacol., 22, 171-176.